The Series C round was led by SoftBank Vision Fund 2* with participation from new investor Steadfast Capital Ventures, and returning investors DCM, General Catalyst, Norwest Venture Partners, and Bling Capital.
New York Bone & Joint Specialists: New Invention Stops or Delays the Progression of Osteoarthritis of the Knee
Leon E. Popovitz, MD, co-founder of New York Bone & Joint Specialists and top orthopedic surgeon in NYC, has invented a bone and joint implant device that has the potential to counteract the effects of osteoarthritis.
March 29, 2021 Author: Jason M. Ferguson Among one of the most serious damages that happen because of automobile crashes, are spine injuries. A spine injury can leave you completely incapacitated. The NINDS or National Institute of Neurological Problems...
FDA Advises Patients, Caregivers and Providers of Risk of Breakage of Total Ankle Replacement Device
"After reviewing long-term data from an FDA-required post-approval study, published literature, real-world evidence and adverse event reports, we're taking action to advise patients, their caregivers and health care providers of the higher than expected rate of fractures—or breakage—of a plastic component in the Scandinavian Total Ankle Replacement, or STAR Ankle device.
Confidence USA Inc.: Federal Judge Enters Permanent Injunction Against New York-based Dietary Supplement Manufacturer
The permanent injunction requires the defendants to cease manufacturing, holding, or distributing dietary supplements until the FDA notifies defendants that they may resume operations.
Lumen, the creators of the world's first metabolism measurement device through the breath, has further validated the effectiveness of HIIT (workouts by measuring their impact on our metabolism.
Most people know that excess weight is a major risk factor for many serious health conditions — including heart disease, stroke, type 2 diabetes and some forms of cancer — but obesity rates have continued to rise for decades.
"This indicates that a gigantic 'healthcare debt' has been built up which will be a real challenge for the Swedish healthcare system to deal with in the coming year," says George Thaw, CEO of medtech company FRISQ, which conducted the survey.